Venous Ulcer Treatment Market Projected to Gain Significant Value through 2033

From 2023 to 2033, the global Venous Ulcer Treatment market revenue is expected to be worth US$ 2.96 billion, with a compound annual growth rate (CAGR) of 6.5%. By the end of the projected period, the market is expected to be worth US$ 7.61 billion. According to the NHS, venous ulcers are the most common cause of leg ulcers, accounting for more than 90% of all cases and affecting around 1 in 500 persons in the UK. The key factors driving market growth in the next years will be an increase in the incidence of venous ulcers and an increase in the deployment of compression treatment for venous leg ulcers. Increased awareness of the availability of therapeutic interventions for venous ulcers, as well as therapeutic breakthroughs, are projected to boost the Venous Ulcer Treatment market throughout the forecast period.

North America will lead the worldwide Venous Ulcer Treatment industry in 2022. It is likely to lead the market over the forecast years. The European Venous Ulcer Treatment market is likely to grow at a rapid pace in the future years. The widespread use of wound management chemicals in numerous developing economies, including the United Kingdom, has generated significant revenue over the years. North America led the global market in 2022 and is expected to continue to do so in the coming years. As more people employ advanced wound care items and therapeutic methods, particularly negative pressure wound treatment, the regional market is expanding. Continued R&D on these will expand new revenue potential in the foreseeable future.

Key Market Players

Significant players in the Venous Ulcer Treatment market are Angiodynamics, Sigvaris Global, Medi GmbH & Co. KG, Activa Healthcare, 3M, Medtronic, Bristol Myers Squibb Co, Sanofi, Bayer AG, Pfizer Inc, Novo Nordisk A/S. Some of the latest developments are:

Browse More Details@ https://www.futuremarketinsights.com/reports/venous-ulcer-treatment-market

Key Segments Profiled in the Venous Ulcer Treatment Market Industry Survey 

By Diseases Type:

  • Arterial Ulcers
  • Neurotropic Ulcer
  • Venous Ulcers
  • Diabetic Ulcers

By Treatment Type:

  • Compression Treatment
  • Surgical Treatment
  • Skin Grafting
  • Advanced Wound Dressing

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more